ARTICLE | Company News
Sun to acquire DUSA
November 9, 2012 1:41 AM UTC
Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA) will acquire dermatology company DUSA Pharmaceuticals Inc. (NASDAQ:DUSA) for $8 per share in cash, or about $230 million. The price is a ...